共 19 条
- [1] ASO H, 1989, J BIOL RESP MODIF, V8, P180
- [3] Buege J A, 1978, Methods Enzymol, V52, P302
- [4] ANTIATHEROGENIC EFFECT OF PROBUCOL UNRELATED TO ITS HYPOCHOLESTEROLEMIC EFFECT - EVIDENCE THAT ANTIOXIDANTS INVIVO CAN SELECTIVELY INHIBIT LOW-DENSITY-LIPOPROTEIN DEGRADATION IN MACROPHAGE-RICH FATTY STREAKS AND SLOW THE PROGRESSION OF ATHEROSCLEROSIS IN THE WATANABE HERITABLE HYPERLIPIDEMIC RABBIT [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7725 - 7729
- [5] ESTERBAUER H, 1987, J LIPID RES, V28, P495
- [6] CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01): : 67 - 75
- [8] HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1
- [9] 2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells [J]. EXPERIENTIA, 1996, 52 (02): : 159 - 166
- [10] COMPARATIVE-STUDY ON THE EFFECT OF LOW-DOSE VITAMIN-E AND PROBUCOL ON THE SUSCEPTIBILITY OF LDL TO OXIDATION AND THE PROGRESSION OF ATHEROSCLEROSIS IN WATANABE HERITABLE HYPERLIPIDEMIC RABBITS [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (08): : 1386 - 1391